Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics - Oligonucleotide Therapeutics Society

Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics

OTS

Reviews

April 30, 2018

SHARE

Post Views: 314

Urbanski LM, Leclair N, Anczuków O.
Wiley Interdiscip Rev RNA. 2018 Apr 25:e1476.

Related articles

Subscribe to our Newsletter

Oligonucleotide Therapeutics Society

Oligonucleotide Therapeutics Society

c/o Event Innovations, Inc.
4377 Newport Avenue
San Diego, CA 92107, USA

(619) 795-9458
info@oligotherapeutics.org

Terms & Conditions

Resources

Stay Connected

Search

Subscribe in a reader

© Copyright 2012 – 2022 | Oligotherapeutics.org | All Rights Reserved | Finfrock Marketing

Username/Email Address:
Password:
Forgot Password | Sign Up

Save Password

First Name *
Last Name *
Username *
Email *
Password *
Confirm Password *
Phone:
Organization Name
Select Sectors

By clicking checkbox, you agree to our Terms and Conditions and Privacy Policy

Already have an account? Login

This website uses cookies and third party services. Ok